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A B S T R A C T
Background
Sexually transmitted disease (STD) prevention remains a public health priority. Simple,
practical interventions to reduce STD incidence that can be easily and inexpensively
administered in high-volume clinical settings are needed. We evaluated whether a brief video,
which contained STD prevention messages targeted to all patients in the waiting room,
reduced acquisition of new infections after that clinic visit.
Methods and Findings
In a controlled trial among patients attending three publicly funded STD clinics (one in each
of three US cities) from December 2003 to August 2005, all patients (n ¼ 38,635) were
systematically assigned to either a theory-based 23-min video depicting couples overcoming
barriers to safer sexual behaviors, or the standard waiting room environment. Condition
assignment alternated every 4 wk and was determined by which condition (intervention or
control) was in place in the clinic waiting room during the patient’s first visit within the study
period. An intent-to-treat analysis was used to compare STD incidence between intervention
and control patients. The primary endpoint was time to diagnosis of incident laboratory-
confirmed infections (gonorrhea, chlamydia, trichomoniasis, syphilis, and HIV), as identified
through review of medical records and county STD surveillance registries. During 14.8 mo
(average) of follow-up, 2,042 patients (5.3%) were diagnosed with incident STD (4.9%,
intervention condition; 5.7%, control condition). In survival analysis, patients assigned to the
intervention condition had significantly fewer STDs compared with the control condition
(hazard ratio [HR], 0.91; 95% confidence interval [CI], 0.84 to 0.99).
Conclusions
Showing a brief video in STD clinic waiting rooms reduced new infections nearly 10% overall
in three clinics. This simple, low-intensity intervention may be appropriate for adoption by
clinics that serve similar patient populations.
Trial registration: http://www.ClinicalTrials.gov (#NCT00137670).
The Editors’ Summary of this article follows the references.
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Introduction
Approximately 19 million incident cases of sexually trans-
mitted infections occur in the United States annually [1].
While several effective interventions have been developed for
patients at risk for infection [2–6], these interventions
typically focus on individual or group risk reduction, involve
multiple sessions, and require signiﬁcant resources to imple-
ment. Simple, practical interventions that can reduce sexually
transmitted disease (STD) incidence in high-volume clinical
settings are needed to complement existing prevention
activities.
Video interventions offer a pragmatic mechanism for
delivering STD prevention messages because of their relative
low cost and ease of implementation, likely acceptability, and
high likelihood of being adopted and sustained if found
effective. In previous studies of STD clinic patients, brief
video-based interventions, typically combined with individual
or small-group counseling, have been associated with
reductions in risky sexual behavior [7,8] and new infections
[9,10]. However, the complexity and expense of administering
these behavioral interventions may present barriers to
adoption and implementation that simply showing a video
does not.
We conducted a controlled multisite trial to evaluate
whether a brief video, which contained STD prevention
messages targeted to all patients in the waiting room, was
effective in reducing acquisition of new infections after that
clinic visit.
Methods
Patients, Sites, and Consent
The trial was conducted at three public STD clinics, one
each in Denver (Colorado), in Long Beach (California), and
San Francisco (California) from December 2003 through
August 2005. All patients attending those clinics during that
20-mo period were included.
The institutional review boards at each site and the Centers
for Disease Control and Prevention reviewed and approved
the study protocol (Text S1). A waiver of informed consent
was obtained, given that patients were not actively recruited
and only routinely collected data were used. A CONSORT
checklist was completed for this study (Text S2).
Study Design
We used a controlled trial design, in which the intervention
condition (i.e., the video Safe in the City, supplemented by
movie-style posters) and the control condition (i.e., standard
waiting room experience) were systematically administered in
alternating 4-wk blocks of time. Routinely collected data were
abstracted electronically (Denver and San Francisco) or
manually (Long Beach) from clinic medical records for dates
of the index visit (i.e., ﬁrst visit during the study period) as
well as dates of all subsequent clinic visits, reason for index
visit, date of birth, sex, race/ethnicity, age, and sexual
orientation, and STD diagnoses at both initial and subse-
quent visits. Clinical medical record data and external county
STD surveillance registries were reviewed after completion of
follow-up (December 2005) to identify and compare incident
infections between groups of patients deﬁned by the study
condition at their index visit.
For condition assignment, we used a blocking scheme
consisting of 11 identical 8-wk cycles (4 wk for control and 4
wk for intervention). This block length was selected to
minimize contamination between conditions and avoid
biases from secular trends in STD incidence. The order of
condition assignment for the ﬁrst cycle (i.e., control followed
by intervention) was randomly determined by a coin toss.
This order was maintained throughout the trial in each
clinic.
Based on an integrated theoretical approach to achieving
health behavior change [11–14], the intervention condition
consisted of a video that incorporated key prevention
messages aimed at increasing knowledge and perception of
STD/HIV risk, promoting positive attitudes toward condom
use, and building self-efﬁcacy and skills to facilitate partner
treatment, safer sex, and the acquisition, negotiation, and use
of condoms. The 23-min video contained three discrete,
related vignettes that modeled young couples of diverse
racial/ethnic backgrounds and sexual orientations in various
types of relationships negotiating safer sexual behavior (Text
S3). Animated segments demonstrated proper condom use
and the variety of condoms available. Posters in the waiting
room and exam rooms directed attention to the video and
reinforced key messages. Additional details regarding the
development and content of the Safe in the City intervention
have been reported elsewhere [15] and can be found at http://
www.safeinthecity.org. During each intervention cycle, each
site monitored intervention exposure (i.e., viewership) by
anonymously surveying a convenience sample of approx-
imately 25 patients after their clinic visit. The frequency with
which the video was played was adjusted accordingly in an
effort to maximize coverage until 80% of sampled clinic
attendees reported seeing most or all of the video and could
identify a key prevention message.
For the control condition, patients experienced the stand-
ard waiting room environment, in the absence of video and
posters. This condition differed by site and included tele-
vision programming, music, or both.
Condoms and educational pamphlets on STD prevention
were available to all patients in both conditions throughout
the study period.
Outcomes
For primary outcomes, incident STDs included laboratory-
conﬁrmed diagnoses of gonorrhea, chlamydia, trichomoniasis
(females only), primary or secondary syphilis, and HIV
infection, as documented in clinic records or review of local
notiﬁable disease registries. For the latter, incident infections
for reportable STDs in California and Colorado (gonorrhea,
chlamydia, syphilis, and HIV) were matched to patient clinic
records based on ﬁrst and last names and dates of birth, and/
or SOUNDEX code algorithms. Incident diagnoses were
deﬁned as follows: for gonorrhea and chlamydia, a positive
cervical, urethral, or rectal test by Gram stain, culture, or
urine-based screening (the latter being used most commonly
at all three clinics); for trichomoniasis, clinical diagnosis
supplemented by a positive wet mount; for primary or
secondary syphilis, positive test result (i.e., darkﬁeld micro-
scopy or RPR/MHA-TP) with clinical diagnosis; and for HIV,
documented positive antibody test by standard EIA/WB
algorithm following negative antibody test in the same clinic.
For these STDs, an incident infection was deﬁned as any
laboratory-conﬁrmed infection diagnosed after the index
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visit. The one exception was that we excluded infections from
patients who received the same diagnosis at the index and
follow-up visits within 30 d; these infections may have
represented persistent positive diagnostic test results. Each
clinic followed standard local protocols for testing, diagnosis,
and treatment of STDs as well as partner notiﬁcation that
were consistent with existing national guidelines.
Statistical Analysis
In designing the study, we assumed 5% per year cumulative
incidence of these STDs in the absence of intervention, and
thus estimated that a sample size of approximately 45,000
patient record abstractions would be required to detect a
10% reduction in annual STD incidence with 80% power at
the 10% signiﬁcance level when based on a comparison of
two binomial proportions. Condition assignments were
masked for analysts and investigators during primary
analyses.
Medical records and surveillance data were reviewed for all
patients with valid visit dates, although we excluded 1,647
patients (,5%) from analyses a priori because they partici-
pated in a separate behavioral assessment of this intervention
involving active follow-up. Inclusion of these patients did not
alter results. Following an intent-to-treat approach, we used
the Kaplan-Meier survival method with the Greenwood
variance estimator to compute cumulative STD incidence
and to compare incidence between conditions as a function
of time from the index clinic visit [16]. Patient observation
time was censored at the time of diagnosis for the ﬁrst new
laboratory-conﬁrmed infection or the end of follow-up.
Unless documented in local notiﬁable disease registries,
patients in both conditions who did not return to the clinics
during the study period, as well as those who returned but did
not receive a diagnosis of new infection, were assumed not to
have incident STD. Because the systematic assignment of
condition (i.e., control followed by intervention) resulted in
control patients having an additional 4 wk of follow-up as
compared with intervention patients, we repeated all primary
analyses such that the end date of follow-up for control
patients ended 4 wk earlier; these analyses also did not alter
results.
Cox proportional hazards models were developed to
estimate hazard ratios for the effect of condition assignment
on STD incidence over time. The models were ﬁtted with a
single covariate (study condition) for the primary analysis to
assess the overall effect of the intervention. We additionally
performed six planned secondary analyses to assess whether
intervention effects varied by sex, race/ethnicity, age, sexual
orientation, laboratory-conﬁrmed STD diagnosis at the index
visit, and study site. Because of the exploratory nature of
these secondary analyses, no adjustments were made for
multiple comparisons. Apart from estimating intervention
effects, we also conducted multivariable analyses stratiﬁed by
sex to determine independent risk factors for incident
infection. To be included in the ﬁnal model, all covariates
considered were required to be signiﬁcant or speciﬁed a
priori as risk factors from the existing literature. All models
were found to satisfy assumptions for proportional hazards
modeling and goodness of ﬁt. All analyses were performed by
using SAS statistical software (version 9.1, SAS Institute) and
were conducted by one author (CBB). All statistical tests were
two-tailed and are presented at the more conservative 0.05
signiﬁcance level to minimize the likelihood of type I error.
Results
Data on 38,635 patients who visited participating STD
clinics from December 2003 to August 2005 were included in
analyses (Figure 1). Most patients were male (70%), members
of minority races/ethnicities (54%), aged 25 y or older (69%),
heterosexual (78%), and attended clinics in San Francisco
(51%) or Denver (41%). Overall, 5,990 patients (16%) were
diagnosed with one or more laboratory-conﬁrmed infections
(primarily gonorrhea or chlamydia) at the index visit. The
numbers and characteristics of patients assigned to each
condition were well-matched and approximately equal (Table
1).
Altogether, 15,480 patients (40.1%) returned to the clinic
for a subsequent visit: 8,483 returned for one visit, 3,044 for
two visits, and 3,953 for three or more visits. Neither the
overall proportions of patients who made return visits (40.1%
for intervention versus 40.0% for control; Fisher exact test, p
¼ 0.86) nor the mean numbers of return visits (0.80 visits for
intervention versus 0.85 visits for control; Wilcoxon test, p ¼
0.39) differed signiﬁcantly by condition.
Of the subgroup of 756 patients anonymously surveyed
during intervention periods to broadly monitor intervention
exposure, 576 (76%) reported viewing ‘‘most’’ or ‘‘all’’ of the
video and identiﬁed at least one of ﬁve main prevention
messages noted earlier that were designated a priori by
investigators. Intervention exposure in this subgroup was
signiﬁcantly higher among patients who reported wait times
of  20 min compared with , 20 min (81% versus 52%;
Fisher exact test, p , 0.001) and at clinics in Denver or Long
Beach (combined) compared with San Francisco (82% versus
68%; Fisher exact test, p , 0.01). Although limited by small
sample sizes, overall viewership levels appeared to remain
constant across intervention periods (range, 71%–87%).
During a mean of 14.8 mo of observation (range 4–24 mo),
one or more new laboratory-conﬁrmed STDs were diagnosed
for 2,042 patients (5.3%), comprising 2,418 total infections.
First incident STDs were as follows: 948 patients (2.5%),
gonorrhea (409 intervention, 539 control); 1,239 patients
(3.2%), chlamydia (573 intervention and 666 control); 142
patients (0.4%), trichomoniasis (71 intervention and 71
control); 75 patients (0.2%), primary or secondary syphilis
(35 intervention and 40 control); and 14 patients (, 0.1%),
HIV infection (four intervention and ten control). Multiple
STDs were diagnosed for some patients. Most patients
diagnosed with an STD (77%) received diagnoses in the STD
clinics as opposed to other facilities, as reported through
disease registries; the proportions of patients receiving clinic
diagnoses were similar between conditions (77.3% for inter-
vention versus 76.5% for control; Fisher exact test, p¼ 0.67).
Fewer incident infections were diagnosed for patients
assigned to the intervention condition than for patients
assigned to the control condition (4.9% versus 5.7%) (Table
2). The largest reductions in the numbers of new infections
were observed for gonorrhea and chlamydia. Cumulative STD
incidence was consistently lower among patients in the
intervention than in the control condition, beginning at 6
mo after the index visit (Figure 2). Intervention exposure
signiﬁcantly reduced STD incidence (overall hazard ratio
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[HR], 0.91; 95% conﬁdence interval [CI], 0.84 to 0.99). The
point estimate for the intervention effect remained essen-
tially unchanged when observation times were additionally
censored upon the date of the ﬁrst documented exposure to
the alternate study condition (i.e., when patients in the
control group were ﬁrst exposed to the intervention
condition, and vice versa) (overall HR, 0.90; 95% CI, 0.81 to
1.00). Similar intervention effects also were observed when
analyses were restricted to the two most common incident
infections (gonorrhea and chlamydia), regardless of whether
observation times were censored (overall HR, 0.89; 95% CI,
0.80 to 0.99) or not (overall HR, 0.91; 95% CI, 0.83 to 1.00).
The intervention effect also was similar when we limited
infections only to those identiﬁed in participating STD clinics
by excluding infections identiﬁed through county disease
registries (overall HR, 0.92; 95% CI, 0.83 to 1.02).
Planned subgroup analyses suggested that reductions in
STD incidence were statistically signiﬁcant among interven-
tion (versus control) patients who received STD diagnoses at
the index visit (HR, 0.86), who were  25 y old (HR, 0.85), who
were male (HR, 0.87) (particularly heterosexual males [HR,
0.84]), and who attended the San Francisco clinic (HR, 0.87),
but not their counterparts (Table 2). No signiﬁcant inter-
vention effect was observed among females (HR, 1.06).
Multivariable analyses stratiﬁed by sex revealed several risk
factors predictive of incident infection (Table 3). For males,
signiﬁcant predictors of subsequent infection included being
African American or Hispanic, , 25 y old, reporting sex with
other males, and receiving an STD diagnosis at the index visit.
For females, signiﬁcant predictors included being African
American or Hispanic, , 25 y old, and receiving an STD
diagnosis at the index visit.
Discussion
Compared with the standard waiting room experience, the
Safe in the City video intervention signiﬁcantly reduced the
incidence of laboratory-conﬁrmed infections among patients
attending these STD clinics. Given the large number of
patients visiting public STD clinics annually, the approx-
imately 10% effect size observed in this study could result in
clinically meaningful reductions in new infections if applied
to clinics with similar populations where the intervention is
similarly effective. Clinics may be willing to adopt simple,
low-cost, low-intensity waiting room interventions, which can
be administered with minimal staff time as part of a routine
clinic visit, in addition to more intensive but effective
interventions that require additional patient or staff time
to implement.
Earlier research by O’Donnell et al. [9] and Cohen et al. [10]
Figure 1. Trial Profile
doi:10.1371/journal.pmed.0050135.g001
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found that brief video-based interventions, typically con-
ducted with group or individual counseling, can reduce
infections among speciﬁc groups of STD clinic patients.
Extending that research, our ﬁndings demonstrate that a
video-alone intervention without such counseling can also
reduce infections among entire STD clinic populations. To
our knowledge, only the study by O’Donnell et al. among
African American and Hispanic male patients attending New
York City STD clinics [9] also included a video-alone arm.
Our ﬁndings suggest that patients in these STD clinic
populations generally paid attention to the video despite
competition for their attention in the waiting room (e.g.,
encounters with clinic and administrative staff, cell phone
conversations, availability of reading materials). Using the
waiting room as an opportunity to provide prevention
interventions may maximize the ‘‘teachable moment’’ [17]
during which patients, already cognizant of their elevated
STD risk, may be most amenable and receptive to inter-
vention.
Like previous studies [9,10], our study suggested that there
were signiﬁcant intervention effects among males, older
patients, and patients who had a diagnosis of infection at the
index visit, though our subgroup ﬁndings were the product of
secondary analyses and thus should be interpreted with
caution. Males in particular appear to have beneﬁted from
exposure to the Safe in the City intervention. Among females,
however, we found no evidence of a signiﬁcant beneﬁcial (or
harmful) intervention effect, which may reﬂect a true lack of
video effectiveness, the limitations of using passive follow-up
to ascertain incident STD outcomes (given the asymptomatic
nature of many infections in women), and generally lower
STD incidence and a smaller number of patients among
females. Given that the apparent lack of effect observed in
women is consistent with other studies [7,10], additional
research is needed on the effectiveness of brief interventions
among at-risk females who visit STD clinics and whether such
interventions may be better targeted toward males. We also
observed a signiﬁcant intervention effect only among
patients at the San Francisco clinic, but note that this clinic
had the largest number of patients, the highest proportion of
males, and the highest incidence of new infections, and thus
was most likely to demonstrate a statistically signiﬁcant effect
in subgroup analyses if such an effect was truly present. While
we could not rule out a null effect at the Denver and Long
Beach sites, we note that the intervention effects observed for
these two sites were not statistically different from the
signiﬁcant intervention effect observed in San Francisco
(Wald test, p. 0.10). Because these ﬁndings as a whole suggest
that the intervention may have been more effective in some
patient subgroups than others, the conduct of additional
studies speciﬁcally designed to examine effectiveness in these
groups would be beneﬁcial.
Our ﬁndings are subject to several limitations. Due to the
structural nature of our waiting room intervention, some
patients in the intervention condition probably did not see
the video in its entirety or at all. Additionally, the record
review documented that 26% of patients had been exposed to
the alternative study condition at some point during follow-
up, and we may have missed the point of this exposure for
other patients. The true magnitude of risk reduction is likely
to be greater than our estimate, given that incomplete
exposure and undetected contamination would tend to
obscure intervention effectiveness.
Clinicians also were not blinded to condition assignment,
Table 1. Characteristics of 38,635 Patients Attending STD Clinics in Three U.S. Cities, December 2003–August 2005, by Study Condition
Baseline Characteristics Category Intervention (n ¼ 19,073) Control (n ¼ 19,562)
Sex/gender, % Male 69 70
Female 30 30
Transgender ,1 ,1
Race/ethnicity, % White, non-Hispanic 46 46
Black, non-Hispanic 18 19
Hispanic 25 25
Other/missing 11 11
Age, y, % , 25 31 31
 25 69 69
Site, % San Francisco 51 51
Denver 41 41
Long Beach 8 8
Sexual orientation (males only), % Heterosexual 69 69
Men who have sex with men 31 31
Laboratory-confirmed infection at index visit, %a Yes 16 15
Yes, gonorrhea 6 5
Yes, chlamydia 10 10
Yes, trichomoniasis 1 1
Yes, syphilis ,1 ,1
Yes, HIV ,1 ,1
No 84 85
Reason for index visit, % New symptoms 56 55
Contact to an STD 10 10
Other b 34 35
aIncludes gonorrhea, chlamydia, trichomoniasis (females only), primary or secondary syphilis, or HIV infection.
bIncludes, for example, visits for routine STD screening / check-up, follow-up for a previous positive test, HIV testing, emergency contraception, and family planning.
doi:10.1371/journal.pmed.0050135.t001
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which could introduce bias if provider knowledge of study
condition affected decisions on which patients received STD
screening during the observation period. For bias to have
affected ascertainment of study outcomes, however, clinicians
would have needed to know what condition patients were
initially assigned to when providing care. We believe this
scenario to be unlikely given that condition assignment was
based exclusively on the date of the index visit and not on the
date of or study condition present at subsequent clinic visits.
Further, condition assignment was not recorded in the
patient’s clinic record. The fact that the proportion of
patients in each condition who were infected with STD was
perfectly balanced at the index visit (when condition assign-
ment was most likely to be known to providers) suggests that
the likelihood of such bias during follow-up was small.
These ﬁndings are also limited by the use of passive follow-
up to ascertain incident STD outcomes, rather than active
laboratory screening. The record-based approach used to
identify new infections is efﬁcient for studies in which large
numbers of observations require follow-up; however, this
approach cannot capture undetected asymptomatic infec-
tions or account for patient migration, and, as a result, may
underestimate STD incidence. Nevertheless, despite the large
sample size required for studying this low-intensity inter-
vention, we were able to use laboratory-conﬁrmed STD
outcomes, as opposed to only behavioral or social psycho-
logical measures, to measure intervention impact, the
importance of which has been well described [6,18,19]. The
intervention also did not appear to alter care- or treatment-
seeking behavior of patients assigned to the video interven-
tion, as the same proportion of patients in both study arms
returned to the STD clinic during the study period,
irrespective of whether they were diagnosed with incident
STD; this suggests minimal bias in our study design. Only one
public STD clinic was located in each city, and return visits
were documented for similar proportions of patients in each
condition. Although we lacked information for individual
records on factors such as whether partner notiﬁcation and
treatment services were accessed, the fact that patients in
both study conditions encountered the same basic clinic
services in alternating months—and were remarkably similar
to each other—suggests that these issues cannot explain the
ﬁnding of reduced STD risk associated with intervention
exposure. These factors, taken together, suggest that the
observed reduction in STD incidence was both real and likely
to be an underestimate of the true effect.
Our study design also had several strengths. Compared with
previous studies of behavioral interventions in STD clinics,
this evaluation was conducted under actual clinic conditions
rather than controlled study conditions. By incorporating
our intervention into the natural waiting room environment,
we directly observed the effectiveness of Safe in the City in
reducing new infections among large populations of STD
clinic patients. Because our evaluation included all clinic
patients, our ﬁnding of reduced STD incidence is likely
generalizable to patients at these clinics and likely to STD
clinics with similar patient proﬁles. Additionally, our design
did not require active consent and thus avoided many typical
threats to external validity that are introduced by narrow
eligibility criteria, low or differential participation rates
across conditions, and the provision of ﬁnancial incentives.
Since patients were not actively enrolled in (and thus were
likely unaware of) our evaluation of Safe in the City as a
structural waiting room intervention, biases associated with
Table 2. Association Between Intervention Exposure and Diagnosis of Incident Laboratory-confirmed Infection a among Patients at
STD Clinics in Three U.S. Cities, December 2003–August 2005, by Selected Patient Characteristics
Characteristic Category Intervention Control Hazard Ratio for
Condition Effect
(95% CI)c
No.
Patients
No. (%) Patients
with New STD
No.
Patients
No. (%) Patients
With New STD
All patients — 19,073 929 (4.9) 19,562 1,113 (5.7) 0.91 (0.84, 0.99)
Sex/gender Male 13,219 660 (5.0) 13,715 843 (6.1) 0.87 (0.78, 0.96)
Female 5,819 267 (4.6) 5,804 267 (4.6) 1.06 (0.89, 1.25)
Transgender 34 2 (5.9) 43 3 (7.0) 0.88 (0.15, 5.29)
Race/ethnicity White, non-Hispanic 8,752 356 (4.1) 8,957 399 (4.5) 0.97 (0.84, 1.12)
Black, non-Hispanic 3,488 277 (7.9) 3,615 341 (9.4) 0.91 (0.78, 1.07)
Hispanic 4,838 216 (4.5) 4,974 272 (5.5) 0.87 (0.72, 1.04)
Other/missing 1,995 80 (4.0) 2,016 101 (5.0) 0.86 (0.64, 1.16)
Age, y ,25 5,987 359 (6.0) 6,041 376 (5.5) 1.02 (0.88, 1.17)
25 13,084 570 (4.4) 13,521 737 (6.2) 0.85 (0.77, 0.95)
Site San Francisco 9,773 513 (5.2) 9,942 645 (6.5) 0.87 (0.78, 0.98)
Denver 7,785 385 (4.9) 8,009 436 (5.4) 0.94 (0.82, 1.08)
Long Beach 1,515 31 (2.0) 1,611 32 (2.0) 1.13 (0.69, 1.85)
Sexual orientationb Heterosexual 9,071 256 (2.8) 9,302 333 (3.6) 0.84 (0.71, 0.98)
Men who have sex
with men
4,038 398 (9.9) 4,318 507 (11.7) 0.90 (0.79, 1.03)
Laboratory-confirmed
infection at index visit
Yes 2,982 349 (11.7) 3,008 482 (16.0) 0.86 (0.75, 0.99)
No 16,091 580 (3.6) 16,554 685 (4.1) 0.93 (0.84, 1.04)
aIncludes gonorrhea, chlamydia, trichomoniasis (females only), syphilis (primary or secondary), or HIV infection.
bMales only.
cResults were calculated using Cox proportional hazards regression and are shown with Wald confidence intervals.
doi:10.1371/journal.pmed.0050135.t002
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study participation (e.g., Hawthorne effect) were eliminated.
Further suggesting the generalizability of our ﬁndings, we
note that several identiﬁed predictors of infection were the
same as those reported in other studies of STD clinic
populations (e.g., men who have sex with men, young age,
and infection at the index clinic visit) [10,20–23].
Finally, we successfully designed a study to assess inter-
vention effectiveness in a clinic waiting room environment,
where individual random assignment was neither possible nor
practical. Although our study was not individually random-
ized, by systematically allocating patients to study conditions
in alternating blocks, we successfully balanced the key
characteristics of patients in both study conditions in terms
of all measured covariates, thus likely approximating the
Figure 2. Laboratory-Confirmed Infection among Patients at Sexually Transmitted Disease Clinics in Three U.S. Cities, December 2003 through August
2005, by Study Condition
doi:10.1371/journal.pmed.0050135.g002
Table 3. Factors Associated with Diagnosis of Incident Laboratory-confirmed Infection among Patients at STD Clinics in Three U.S.
Cities, December 2003–August 2005, by Sex a
Characteristic Category Males (n ¼ 26,934) Females (n ¼ 11,623)
Unadjusted Hazard
Ratio (95% CI)
Adjusted Hazard
Ratio (95% CI) b
Unadjusted Hazard
Ratio (95% CI)
Adjusted Hazard
Ratio (95% CI) b
Study condition Intervention 0.87 (0.78, 0.96) 0.88 (0.80, 0.98) 1.06 (0.89, 1.25) 1.02 (0.86, 1.21)
Control Referent Referent Referent Referent
Race/ethnicity Black, non-Hispanic 1.76 (1.56, 2.00) 2.41 (2.11, 2.75) 4.29 (3.40, 5.42) 3.91 (3.09, 4.95)
Hispanic 0.99 (0.87, 1.13) 1.17 (1.02, 1.34) 2.38 (1.86, 3.05) 2.20 (1.71, 2.83)
Other/missing 1.10 (0.91, 1.33) 1.10 (0.91, 1.33) 1.53 (1.10, 2.14) 1.54 (1.10, 2.16)
White, non-Hispanic Referent Referent Referent Referent
Age, y ,25 1.14 (1.02, 1.28) 1.42 (1.26, 1.61) 2.00 (1.68, 2.38) 1.87 (1.56, 2.23)
25 Referent Referent Referent Referent
Site San Francisco 2.51 (1.85, 3.41) 2.16 (1.58, 2.94) 2.10 (1.32, 3.32) 2.93 (1.85, 4.66)
Denver 1.88 (1.38, 2.57) 1.96 (1.44, 2.69) 2.79 (1.18, 4.39) 2.72 (1.72, 4.28)
Long Beach Referent Referent Referent Referent
Sexual orientation c Men who have sex
with men
3.37 (3.04, 3.74) 3.90 (3.46, 4.39) NA NA
Heterosexual Referent Referent NA NA
Laboratory-confirmed
infection at index visit
Yes 3.70 (3.34, 4.11) 3.00 (2.70, 3.33) 3.24 (2.71, 3.89) 2.49 (2.06, 3.00)
No Referent Referent Referent Referent
aIncludes gonorrhea, chlamydia, trichomoniasis (females only), syphilis (primary or secondary), or HIV infection.
bModels adjusted for variables listed in the table. Results were calculated using Cox proportional hazards regression and are shown with Wald confidence intervals.
cMales only.
NA, not applicable.
doi:10.1371/journal.pmed.0050135.t003
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primary beneﬁts obtained from randomization [24,25]. Given
our aim to assess the real-world impact of the intervention
for clinic populations, this study represents an experimental
design that was among the most rigorous options for
evaluating intervention effectiveness. Similar examples of
designs with minimal bias have been noted by others [6,24,26].
In summary, we found that showing a brief informational
and skills-building video intervention in STD clinic waiting
rooms, without a counseling component, decreased new STDs
among high-risk patients in three urban clinics. As has been
shown with video-based health interventions (e.g., tobacco
cessation and proper antibiotic use) in other settings [27–29],
these interventions have the potential to reach large numbers
of STD clinic patients efﬁciently and to be acceptable to
clinic staff because they are easy to implement and
inexpensive. Given that STD clinics account for only a
minority of diagnosed infections [30], future research should
evaluate the appropriateness, applicability, and effectiveness
of video interventions in other settings serving at-risk
populations, including family planning clinics, adolescent
clinics, jails and detention centers, urgent care settings, and
private clinic settings. Additional research could also focus on
identifying the particular element(s) of video-based inter-
ventions (e.g., prevention messages regarding condom use,
partner treatment, and/or partner communication, stimula-
tion of patient communication with providers) that facilitate
reductions in new infections among STD clinic populations,
as was observed in this and other studies [9,10]. This
information is critical for developing similar low-intensity
interventions utilizing video, given that the cultural appeal of
videos to patients may change over time [27]. Future research
focused on how best to implement these types of video-based
interventions within the infrastructure of high-volume clinics
serving similar patient populations would prove both
beneﬁcial and useful.
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Editors’ Summary
Background. In the US alone there are 19 million new cases of sexually
transmitted diseases (STDs) every year. STDs are infections that pass
between people during sexual activity (through semen, vaginal fluids,
blood, or skin-to-skin contact). Some STDs are caused by bacteria (for
example, chlamydia, gonorrhea, and syphilis). Others are caused by
parasites (for example, trichomoniasis) or viruses (for example, herpes
simplex virus and HIV). Symptoms vary among STDs but may include
sores, unusual lumps and itching in the genital region, pain when
urinating, and unusual genital discharge. While symptoms are generally
more common in men than women, many STDs cause no symptoms.
Untreated STDs are more serious for women and may include pelvic
inflammatory disease (PID), ectopic pregnancy, infertility, and chronic
pain. Bacterial and parasitic STDs can be cured with various drugs; STDs
caused by viruses cannot be cured although they can be treated with
antiviral drugs.
Why Was This Study Done? Several interventions have been developed
to educate people at risk of infection about risky sexual behavior and to
teach them the personal skills needed to avoid unsafe sex (for example,
negotiation skills that help them persuade their partner to use a
condom). Although these interventions reduce the incidence of STDs,
they usually involve several sessions of individual or group counseling
and are likely too complex and expensive to implement in busy STD
clinics. In this study, the researchers ask whether a short video that
contains key STD prevention messages can reduce the acquisition of
new infections among patients who watch the video while sitting in the
waiting room of an STD clinic (a ‘‘teachable moment’’ when people are
likely to be receptive to messages about health risks).
What Did the Researchers Do and Find? The researchers developed a
23-minute soap-opera style video—‘‘Safe in the City’’—that contained
three interwoven dramas about young people in various types of
relationships negotiating safer sexual behavior, and two animation
segments about condoms. The researchers showed this video (and
displayed related posters) in the waiting rooms of three US publicly
funded STD clinics every alternate month over a 20-month period. Nearly
20,000 patients were exposed to this intervention. Another 20,000
‘‘control’’ patients who attended the clinics in the months when the
video was not shown were exposed to a standard waiting room
environment in which only leaflets about STDs and condoms were
available. The researchers then reviewed medical records and STD
surveillance registries to find out how many patients in each group
developed laboratory-confirmed STD after their initial clinic visit. Their
statistical analyses show that the intervention reduced the number of
new STD diagnoses by nearly 10%. The intervention was most effective
among patients who had had an STD at their first visit and among men,
but did not appear to reduce the chances of women acquiring an STD.
What Do These Findings Mean? These findings suggest that showing a
brief, carefully designed video in STD clinic waiting rooms might be a
simple, effective way to reduce the incidence of STDs. More research is
needed to discover which parts of the video—those that increase
knowledge and perception of STD risk, those that promote positive
attitudes toward condom use, or those that provide the necessary skills
to negotiate safe sexual practices—are the most effective and why the
video appeared to be more effective for some groups of patients than
others. The intervention also needs to be tested in other types of clinics
but if it works as well elsewhere as in the three study clinics, the
widespread implementation of this low-cost, low-intensity waiting room
intervention could produce a meaningful reduction in the incidence of
STDs in the US and elsewhere.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050135.
 Information is available from Avert, an international AIDS charity, on
sexually transmitted diseases
 The US Centers for Disease Control and Prevention provides detailed
information about sexually transmitted diseases, including information
about STD prevention (in English and Spanish)
 MedlinePlus also provides a list of links to information about sexually
transmitted diseases (in English and Spanish)
 The MedlinePlus encyclopedia has a page on safe sex (in English and
Spanish)
 The Safe in the CIty Study Group has a project-specific Web site that
provides additional details about the intervention and a mechanism
for ordering the video
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